Safety of <scp>BNT162b2 mRNA COVID</scp> ‐19 Vaccine Batches: A Nationwide Cohort Study
This nationwide cohort study provides reassurance regarding the safety of the BNT162b2 vaccine across different batches used in Denmark. The findings support the overall safety of the vaccine, with no clinically relevant variations in serious adverse event rates between batches.
Authors
- Ingrid Bech Svalgaard
- Anders Hviid (ORCID: https://orcid.org/0000-0002-7509-9127)
Institutions
- Statens Serum Institut (DK)
- University of Copenhagen (DK)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1002/pds.70207
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 1.40